批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2022/03/16 |
SUPPL-20(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/12/02 |
SUPPL-19(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/03/31 |
SUPPL-17(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/02/01 |
SUPPL-16(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2011/08/25 |
SUPPL-15(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2011/08/25 |
SUPPL-13(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2006/10/02 |
SUPPL-10(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2004/08/13 |
SUPPL-6(补充) |
Approval |
Efficacy |
PRIORITY
|
|
|
2002/06/07 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/04/09 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2001/02/02 |
SUPPL-3(补充) |
Approval |
Efficacy |
PRIORITY
|
|
|
1999/07/27 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1999/02/18 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
PRIORITY
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:FERRIC OXYHYDROXIDE 剂型/给药途径:INJECTABLE;INJECTION 规格:EQ 62.5MG IRON/5ML (EQ 12.5MG IRON/ML) 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020955 |
001 |
NDA |
FERRLECIT |
FERRIC OXYHYDROXIDE |
INJECTABLE;INJECTION |
EQ 62.5MG IRON/5ML (EQ 12.5MG IRON/ML) |
Prescription |
Yes |
Yes |
AB |
1999/02/18
|
SANOFI AVENTIS US |
078215 |
001 |
ANDA |
SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE |
FERRIC OXYHYDROXIDE |
INJECTABLE;INJECTION |
EQ 62.5MG IRON/5ML (EQ 12.5MG IRON/ML) |
Prescription |
No |
No |
AB |
2011/03/31
|
WEST-WARD PHARMS INT |